Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in italy

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Ciccodicola, Alfredo ^a   Costa, Valerio ^a,b   Casamassimi, Amelia ^a,b   Esposito, Katherine ^b   Villani, Angela ^c   Capone, Mariaelena ^a   Iannella, Rosa ^a   Schisano, Bruno ^b   Ciotola, Miryam ^b   Di Palo, Carmen ^b   Capone Corrado, Feliciantonia ^c   Santangelo, Franco ^c   Giugliano, Dario ^b  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; POLYMERASE CHAIN REACTION; PROLIFERATIVE RETINOPATHY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BODY MASS; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; REGRESSION ANALYSIS; REGULATORY SEQUENCE;

AGED; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION REGULATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ITALY; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; REGRESSION ANALYSIS; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 58949092541     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/126917     Document Type: Article

References (30)

1. Francis G. A., Fayard E., Picard F., Auwerx J., Nuclear receptors and the control of metabolism Annual Review of Physiology 2003 65 261 311
2. Mukherjee R., Jow L., Croston G. E., Paterniti J. R. Jr., Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists The Journal of Biological Chemistry 1997 272 12 8071 8076
3. Sabatino L., Casamassimi A., Peluso G., A novel peroxisome proliferator-activated receptorγisoform with dominant negative activity generated by alternative splicing The Journal of Biological Chemistry 2005 280 28 26517 26525
4. Rosen E. D., Spiegelman B. M., PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth The Journal of Biological Chemistry 2001 276 41 37731 37734
5. Hasstedt S. J., Ren Q.-F., Teng K., Elbein S. C., Effect of the peroxisome proliferator-activated receptor-γ2 Pro12 Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds The Journal of Clinical Endocrinology and Metabolism 2001 86 2 536 541
6. Yen C.-J., Beamer B. A., Negri C., Molecular scanning of the human peroxisome proliferator activated receptorγ(hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation Biochemical and Biophysical Research Communications 1997 241 2 270 274
7. Semple R. K., Chatterjee V. K. K., O'Rahilly S., PPARγand human metabolic disease The Journal of Clinical Investigation 2006 116 3 581 589
8. Masugi J., Tamori Y., Mori H., Koike T., Kasuga M., Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator- activated receptor-γ2 on thiazolidinedione-induced adipogenesis Biochemical and Biophysical Research Communications 2000 268 1 178 182
9. Knouff C., Auwerx J., Peroxisome proliferator-activated receptor-γcalls for activation in moderation: lessons from genetics and pharmacology Endocrine Reviews 2004 25 6 899 918
10. Andrulionytè L., Zacharova J., Chiasson J.-L., Laakso M., Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC -1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial Diabetologia 2004 47 12 2176 2184
11. Zietz B., Barth N., Spiegel D., Schmitz G., Schölmerich J., Schöffler A., Pro12Ala polymorphism in the peroxisome proliferator- activated receptor-γ2 (PPARγ2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients Experimental and Clinical Endocrinology and Diabetes 2002 110 2 60 66
12. Caramori M. L., Canani L. H., Costa L. A., Gross J. L., The human peroxisome proliferator-activated receptorγ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes Diabetes 2003 52 12 3010 3013
13. Petrovič M. G., Kunej T., Peterlin B., Dovč P., Petrovič D., Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γcoactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARγgene is not Diabetes/Metabolism Research and Reviews 2005 21 5 470 474
14. Sassa Y., Hata Y., Aiello L. P., Taniguchi Y., Kohno K., Ishibashi T., Bifunctional properties of peroxisome proliferator-activated receptorγ1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3 Diabetes 2004 53 5 1222 1229
15. Meirhaeghe A., Amouyel P., Impact of genetic variation of PPARγin humans Molecular Genetics and Metabolism 2004 83 1-2 93 102
16. Muller Y. L., Bogardus C., Beamer B. A., Shuldiner A. R., Baier L. J., A functional variant in the peroxisome proliferator-activated receptorγ2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians Diabetes 2003 52 7 1864 1871
17. Costa V., Conte I., Ziviello C., Identification and expression analysis of novel Jakmip1 transcripts Gene 2007 402 1-2 1 8
18. World Health Organization, Diabetes mellitus: report of a WHO Study Group 1985 727 Geneva, Switzerland World Health Organization
19. Sasieni P. D., From genotypes to genes: doubling the sample size Biometrics 1997 53 4 1253 1261
20. Doney A. S. F., Fischer B., Cecil J. E., Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes Diabetologia 2004 47 3 555 558
21. Herrmann S.-M., Ringel J., Wang J.-G., Staessen J. A., Brand E., Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study Diabetes 2002 51 8 2653 2657
22. Altshuler D., Hirschhorn J. N., Klannemark M., The common PPARγPro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nature Genetics 2000 26 1 76 80
23. Valve R., Sivenius K., Miettinen R., Two polymorphisms in the peroxisome proliferator-activated receptor-γgene are associated with severe overweight among obese women The Journal of Clinical Endocrinology and Metabolism 1999 84 10 3708 3712
24. Wittke-Thompson J. K., Pluzhnikov A., Cox N. J., Rational inferences about departures from Hardy-Weinberg equilibrium American Journal of Human Genetics 2005 76 6 967 986
25. Yamauchi T., Kamon J., Waki H., The mechanisms by which both heterozygous peroxisome proliferator-activated receptorγ(PPARγ) deficiency and PPARγagonist improve insulin resistance The Journal of Biological Chemistry 2001 276 44 41245 41254
26. Bonofiglio D., Gabriele S., Aquila S., Estrogen receptorα binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptorγsignaling in breast cancer cells Clinical Cancer Research 2005 11 17 6139 6147
27. Pershadsingh H. A., Moore D. M., PPARγagonists: potential as therapeutics for neovascular retinopathies PPAR Research 2008 2008 13
28. Muranaka K., Yanagi Y., Tamaki Y., Effects of peroxisome proliferator-activated receptorγand its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model Investigative Ophthalmology and Visual Science 2006 47 10 4547 4552
29. Kim J., Oh Y.-S., Shinn S.-H., Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes Experimental Eye Research 2005 81 1 65 70
30. Chao T.-H., Li Y.-H., Chen J.-H., The 161TT genotype in the exon 6 of the peroxisome-proliferator-activated receptorγgene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers Clinical Science 2004 107 5 461 466